Oriola Corporation’s Interim report 1 January–30 September 2022
Oriola Corporation stock exchange release 27 October 2022 at 8.30 a.m. Oriola Corporation’s Interim report 1 January–30 September 2022 Q3 2022: Solid performance continued despite the inflationary environment Reporting information for 2021 has been restated to reflect Oriola’s operating model change announced in October 2021 and the framework merger agreement with Euroapotheca to combine the respective pharmacy businesses in Sweden, announced in February 2022. The restated information, which was published on 26 April 2022, includes the new segment structure. Continuing operations